메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Abraham Joel (Department of General and Upper Gastrointestinal Surgery, James Cook University Hospital, Cleveland, UK) Alakh Konjengbam (Department of General and Upper Gastrointestinal Surgery, James Cook University Hospital, Cleveland, UK) Yirupaiahgari Viswanath (Department of General and Upper Gastrointestinal Surgery, James Cook University Hospital, Cleveland, UK) Georgios Kourounis (Department of General and Upper Gastrointestinal Surgery, James Cook University Hospital, Cleveland, UK) Emily Hammond (Department of General and Upper Gastrointestinal Surgery, James Cook University Hospital, Cleveland, UK) Helen Frank (Department of General and Upper Gastrointestinal Surgery, James Cook University Hospital, Cleveland, UK) Shivani Kuttuva (Department of General and Upper Gastrointestinal Surgery, James Cook University Hospital, Cleveland, UK) Simon Mbarushimana (Department of General and Upper Gastrointestinal Surgery, James Cook University Hospital, Cleveland, UK) Hena Hidayat (Department of General and Upper Gastrointestinal Surgery, James Cook University Hospital, Cleveland, UK) Srivishnu Thulasiraman (Department of General and Upper Gastrointestinal Surgery, James Cook University Hospital, Cleveland, UK)
저널정보
대한소화기내시경학회 Clinical Endoscopy Clinical Endoscopy Vol.57 No.1
발행연도
2024.1
수록면
58 - 64 (7page)
DOI
10.5946/ce.2023.026

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background/Aims: Radiofrequency treatment of the gastroesophageal junction using the Stretta procedure for treating gastroesophageal reflux disease (GERD) is observed to improve the symptoms and proton pump inhibitor (PPI) dependence and reduce the need for anti-reflux operations. As one of the largest studies in Europe, we evaluated the clinical outcomes of Stretta in patients with medically refractory GERD. Methods: A tertiary UK center evaluated all patients with refractory GERD who underwent Stretta between 2014 and 2022. Patients and primary care professionals were contacted to obtain information regarding the initiation of PPI and reintervention after Stretta. Results: Of the 195 patients (median age, 55 years; 116 women [59.5%]) who underwent Stretta, PPI-free period (PFP) data were available for 144 (73.8%) patients. Overall, 66 patients (45.8%) did not receive PPI after a median follow-up of 55 months. Six patients (3.1%) underwent further interventions. The median PFP after Stretta was 41 months. There was a significant negative correlation between PFP and age (p=0.007), with no differences between sexes (p=0.96). Patients younger than 55 years of age had a longer PFP than their older counterparts (p=0.005). Younger males had a significantly longer PFP than older males (p=0.021). However, this was not observed in the female cohort (p=0.09) or between the younger men and women (p=0.66). Conclusions: Our findings suggest that Stretta is a safe and feasible option for treating refractory GERD, especially in younger patients. It prevents further anti-reflux interventions in most patients and increases the lead-time to surgery in patients with refractory GERD.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

최근 본 자료

전체보기

댓글(0)

0